Výsledky vyhledávání - "Julie Zrubek"

Concurrent Oral 6 - Spondylarthropathies [OP40-OP47]: OP40. Association of IL23R and IL12B Polymorphisms with Psoriatic Arthritis

Autor: Charlotte Cavill, Gerald G. Krueger, Nicola Waldron, Dafna D. Gladman, Kirstie L. Haywood, Arthur Kavanaugh, Michael Mack, Andrew M. Garratt, Neil McHugh, A. Barton, Kelvin P. Jordan, Oliver FitzGerald, Joanne Estojak, Laura C. Coates, Emilio Martín Mola, Eleanor Korendowych, Carlos M. González, Pedro Zarco, Anna Beutler, Andrew Keat, Bruce Freundlich, Philip J. Mease, Debbie Robertson, Deepak R Jadon, Jordi Gratacós, Emma L. Healey, Kaushik Patra, Xavier Juanola, Joanne Foehl, Eduardo Collantes, Benjamin Hsu, José Andrés Román Ivorra, Raimon Sanmartí, Bruce Kirkham, Gema Diaz, Jose Luis Fernandez Sueiro, Eduardo Loza, Charles Molta, Surekha Mudivarthy, Jane Skerrett, Chandrabhusan Chattopadhyay, Federico Navarro, Iain B. McInnes, Rubén Queiro, Paul Emery, Ejessie Alfonso, Julie H. Barlow, Désirée van der Heijde, Julie Zrubek, Juan Carlos Torre Alonso, Philip S. Helliwell, Ingrid van der Weide, Frederic Lavie, Jonathan Packham, L. Linares, Juan Mulero

Publikováno v: Rheumatology. 49:i17-i20

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6b12e740dde7f3b7d213d45d9f25d31a
https://doi.org/10.1093/rheumatology/keq706

Zobrazit plný text záznamu

Infliximab Therapy in Children With Concurrent Perianal Crohn Disease: Observations From REACH

Autor: Julie Zrubek, Georges Ferry, Anne M. Griffiths, Harland S. Winter, Wallace Crandall, James Markowitz, Gigi Veereman-Wauters, Subra Kugathasan, Stanley N. Cohen, Robert N. Baldassano, Allan Olson, G Liu, Jeffrey S. Hyams, Robert Heuschkel

Publikováno v: Journal of Pediatric Gastroenterology & Nutrition. 49:183-190

Post hoc analyses evaluated the effect of infliximab upon concurrent perianal Crohn disease (CD) in a subpopulation of 31 patients from REACH, a randomized trial of 112 children with moderately to severely active luminal CD.The Pediatric Crohn Diseas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::678d2ea41e2ba555137c9f6e2c268184
https://doi.org/10.1097/mpg.0b013e3181a70f21

Zobrazit plný text záznamu

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

Autor: Dafna D. Gladman, A. Beutler, Gerald G. Krueger, Michael Mack, Kim A. Papp, Juan J. Gomez-Reino, Arthur Kavanaugh, Iain B. McInnes, Surekha Mudivarthy, Philip J. Mease, Sudha Visvanathan, Julie Zrubek

Publikováno v: Arthritis & Rheumatism. 60:976-986

To assess the efficacy and safety of golimumab in patients with active psoriatic arthritis (PsA). Methods. Adult patients with PsA who had at least 3 swollen and 3 tender joints and active psoriasis were randomly assigned to receive subcutaneous inje

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4516b6c186e7484445d1a3f07b997cef
https://doi.org/10.1002/art.24403

Zobrazit plný text záznamu

Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

Autor: Julie Zrubek, Sudha Visvanathan, Jacek Pazdur, Mark C. Genovese, Edward C. Keystone, Zhong Wu, Mahboob Rahman, Maria Wiekowski, Sang Cheol Bae, Stephen T. Hall, Pedro Miranda, Lars Klareskog, Elizabeth C. Hsia, William E. Palmer

Publikováno v: Annals of the Rheumatic Diseases

Objective: The phase III GO-FORWARD study examined the efficacy and safety of golimumab in patients with active rheumatoid arthritis (RA) despite methotrexate therapy. Methods: Patients were randomly assigned in a 3 : 3 : 2 : 2 ratio to receive place

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::694e6bdc66360aeb466755633e2e0f99
http://europepmc.org/articles/PMC2674549

Zobrazit plný text záznamu

Golimumab in psoriatic arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial

Autor: A. Baratelle, W. Xu, Dafna D. Gladman, Kim A. Papp, Iain B. McInnes, Zhenhua Xu, Surekha Mudivarthy, Juan J. Gomez-Reino, Michael Mack, Philip J. Mease, A. Beutler, Arthur Kavanaugh, Désirée van der Heijde, Mahboob Rahman, Julie Zrubek, Gerald G. Krueger

Publikováno v: Arthritis and Rheumatism, 64(8), 2504-2517

Golimumab, administered subcutaneously every 4 weeks, has been shown to be effective in reducing the signs and symptoms of active psoriatic arthritis (PsA) through week 24 of the GO-REVEAL study. Herein we report 1-year clinical, radiographic, and sa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d452b38d72d829288d1b904ae20568a
https://hdl.handle.net/1887/106317

Zobrazit plný text záznamu

Erratum: Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

Autor: Arthur Kavanaugh, Iain McInnes, Philip Mease, Gerald G. Krueger, Dafna Gladman, Juan Gomez-Reino, Kim Papp, Julie Zrubek, Surekha Mudivarthy, Michael Mack, Sudha Visvanathan, Anna Beutler

Publikováno v: Arthritis & Rheumatism. 62:2555-2555

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3aef901a3b3ed2b7594e711daecfe6e1
https://doi.org/10.1002/art.27673

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání